Previous 10 | Next 10 |
LONDON and SAN FRANCISCO, March 26, 2021 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the submission of an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for VIR-783...
The rise in thematic ETFs in 2020 was remarkable, with assets increasing by 78% in Q4 alone, to $104B in AUM. This meteoric growth has been powered by firms like Defiance, a relative newcomer to the ETF space that has already produced a $1B fund in FIVG. Founded in 2018 by a group...
This continues our series on busting options myths where we explore a different way to sell options. In this article, we discuss myths around selling puts. These myths generally teach: (i) only sell puts on companies you wouldn't mind owning; (ii) selling puts requires a neutral t...
Gainers: NLS Pharmaceutics NLSP +111%, Entera Bio ENTX +75%, Seelos Therapeutics SEEL +34%, Regulus Therapeutics (RGLS) +27%, Rafael (RFL) +27%.Losers: Marker Therapeutics MRKR -28%, Timber Pharmaceuticals (TMBR) -21%, Evoke Pharma EVOK...
Looking For The Best Health Care Stocks To Buy? 4 Making Waves Now It comes as no surprise that the health care sector would be receiving more attention during a pandemic. By extension, this could also include more investors looking for the top health care stocks now. Why? Well,...
Shares of Vir Biotechnology (NASDAQ: VIR) surged 32% on Tuesday after the immunology company announced promising clinical trial results for its COVID-19 antibody treatment. Vir and its partner GlaxoSmithKline (NYSE: GSK) said an independent data monitoring committee ...
Gainers: Entera Bio (ENTX) +223%.Nova LifeStyle (NVFY) +85%.PDS Biotechnology (PDSB) +54%.Phunware (PHUN) +50%.Takung Art (TKAT) +41%.FinVolution (FINV) +36%.RYB Education (RYB) +34%.Vir Biotechnology (VIR) +34%.Siebert Financial (SIEB) +33%.Super League Gaming (SLGG) +27%.Lose...
Nova LifeStyle (NVFY) +231%.Siebert Financial (SIEB) +63% on Q4 results.Vir Biotechnology (VIR) +60% as its and GSK's COVID-19 antibody drug reduces hospitalization, death by 85%.OrganiGram Holdings (OGI) +40% on cannabis product deal with British American Tobacco.China HGS Rea...
An evidence of profound efficacy was found in Vir Biotechnology (VIR) and GlaxoSmithKline's (GSK) Phase 3 COMET-ICE trial evaluating VIR-7831 (GSK4182136) as monotherapy for early treatment of COVID-19 in adults at high risk of hospitalization.An Independent Data Monitoring Committe...
– Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death – – Vir and GSK plan to immediately seek Emergency Use Authorization in the U.S. and authorizations in other countries ...
News, Short Squeeze, Breakout and More Instantly...
Vir Biotechnology Inc. Company Name:
VIR Stock Symbol:
NASDAQ Market:
Vir Biotechnology Inc. Website:
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide financial results for the second quarter ended June 30, 2024, on August 1, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on August 1, 2024. Financial results will ...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
2024-07-08 10:47:03 ET BITX (BITX) BITX is trading DOWN for the last 4 days, and it at trading at $27.48 with volume of 3,908,355 and a one day change of $-0.37 (-1.33%). BITX has a 52-week low of 0.00 and a 52-week high of $0.00. The business's 50-day moving average price is $45.40...